Introduction to Cardiac Mechanosensitivity History and Scope
The heart's propensity to respond to mechanical stimuli with acute changes in its activity has been known for centuries. Early reports in the European medical literature describing mechanical effects on human heart rhythm date back to the 19th century, such as the communications by Nélaton 1 and Meola 2 on sudden death caused by precordial impact.
In parallel, first experimental evidence of mechano-electric feedback (MEF) 10 was reported by Bainbridge, 11 who showed that stretch of the right atrium, containing the heart's primary pacemaker tissue, increases spontaneous beating rate. This "Bainbridge effect" is seen in the denervated heart, including human transplants, [12] [13] [14] ex situ animal hearts, [15] [16] [17] isolated tissue, 18, 19 and even single isolated pacemaker cells, 20 highlighting the intrinsic nature of at least some of the underlying mechanisms. Conceptually related MEF effects are seen in cardiac myocytes [21] [22] [23] [24] and nonmyocytes, [25] [26] [27] highlighting the potential relevance of cardiac MEF for heart function (more details on MEF are available in the collection of works from leading teams edited by Kohl et al 28 ) . This review will focus on one of the contributors to mechanically induced acute changes in cardiac electrophysiology. Their effects are instantaneous, as opposed to more slowly occurring mechanical modulation of contractility, or even longer term mechanically induced changes in gene expression and cell/tissue remodeling. Several mechanosensors of potential relevance for acute MEF responses have been identified. They include enzymes (eg, mechanosensitive kinases), structural elements from molecules (eg, cytoskeletal and transmembrane linkage proteins) to membrane domains (eg, caveolae), or more complex assemblies (eg, contractile filament lattice and z-disks), but of particular interest are ion translocation mechanisms afforded by mechanically gated channels (MGC).
MGC may serve both as sensors and as effectors of MEF responses. Embedded in membranes, they convert mechanical stimuli, putatively including in-plane membrane tension, membrane thickness and curvature, as well as matrix-protein interactions, into electrical and biochemical signals. MGC can affect, therefore, a wide range of cellular processes, with response times in the millisecond domain relevant for acute cardiac MEF.
MGC were discovered in 1984 by Guharay and Sachs 29 in embryonic chick skeletal myocytes. Four years later, Craelius et al 30 published the first MGC recordings from mammalian cardiomyocytes. Since then, in addition to stretch-activated whole-cell currents, single-channel activity has been identified in a wide range of cardiac cells, 31 including atrial myocytes, 32 foetal, 30 and (for potassium-selective MGC at least) adult ventricular myocytes, 33 as well as cardiac nonmyocytes. 27 In the 1990s, the first MGC was cloned from Escherichia coli (mechanosensitive channel of large conductance [MscL] ), 34 and the molecular nature of the first mammalian MGC was reported. 35 Since then, an increasing number of MGC has been identified and a large proportion of them are expressed and functional in the heart ( Figure 1 ).
Because block of MGC in the mammalian heart can prevent certain forms of mechanically induced heart rhythm disturbances in the experimental setting, 36, 37 they form a putative therapeutic target. This has motivated the present assessment of what we know about them so far.
Channel Activation: Mechanical Modulation Versus Mechanical Gating
Mechanically Modulated Ion Channels Versus MechanoGated Ion Channels Nomenclature Ion channels, relevant for MEF, are characterized by their ability to change open probability in direct response to mechanical stimulation. Traditionally, mechanically gated ion channels have been classed according to the stimulus by which they were activated (eg, cell volume-activated channels [VAC] , stretch-activated channels [SAC]; Figure 2 ). However, it is difficult to apply perturbations in a way that alters only one mechanical parameter, even if techniques for controlled mechanical stimulation of membrane patches have improved. [38] [39] [40] In this paper, we refer to MGC as channels that can be activated by a mechanical stimulus alone. Channels that are normally activated by a different type of stimulus but with a gain that is affected by the mechanical environment, or those that require coactivation by nonmechanical stimuli, will be referred to as mechanically modulated channels (MMC).
Voltage-Gated MMC MMC normally classed as voltage-gated include potassium, 41 calcium, [42] [43] [44] and sodium [45] [46] [47] channels. Mechanical modulation of Kv channels (K + channel, voltage-gated) ranges from mechanically induced redistribution (eg, integration of Kv1.5 channels into the sarcolemma of rat atrial myocytes), 48 to direct stretch-induced gating (eg, of Kir channels [K + inwardly rectifying channel] in murine ventricular myocytes). 49 Similarly, voltage-sensitive sodium channels can be affected by the mechanical environment (such as Na V 1. Modification of the channel stability at the membrane is another type of modulation and has recently been exemplified for the L-type calcium channel: polycystin-1, well-known to act as a mechanosensor in several cell types, can stabilize the entire pool of L-type channel proteins in rat cardiomyocytes. 51 Mechanical modulation of voltage-sensitive channel gating is perhaps less surprising than often assumed, given that voltage sensing requires conformational rearrangements of the channel protein. 52 If channel opening is associated with an increase in protein dimensions in the membrane plane, then the open state should be favored by increased membrane tension. That said the precise conformational changes of many ion channels are not known, and it is clear that not all channels are mechanosensitive in standard experimental conditions (eg, TWIK-related acid-sensitive K + channels with TWIK standing for tandem of 2-pore K + domains in a weak inwardly rectifying K + channel).
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Ligand-Activated MMC Both γ-aminobutyric acid and purinergic (P2X) receptors (P2X 3 and P2X 4 subtypes in particular) are expressed in the heart, although not in cardiomyocytes but in neurons and smooth muscle cells, respectively. 54, 55 They were suggested to participate in mechanotransduction processes, but their direct mechanosensitivity remains to be established. P2X 4 is not activated by shear stress alone, and their role in mechanotransduction is suggested to stem from ATP release that can be mechanically induced by them, as shown in endothelial cells. 56 Sarcolemmal K ATP channels (K + channel, ATP inactivated), discovered in cardiac myocytes in the early 1980s, 57 Figure 1. Mechanically gated channel (MGC) and mechanically modulated channel (MMC) candidates are present throughout living organisms. Several mammalian channels have homologues in other organisms: for example, NOMPC, OSM9, TRP4, TRPY1, and LOV-1 are transient receptor potential (TRP) homologues; MEC channels are members of the DEG/ENaC (degenerin/epithelial Na + channel) superfamily whose mammalian representatives are acid-sensing ion channels (ASIC); TPK is a homologue of K 2P channels; Mid1 (mating induced death) is homologous to voltage-gated calcium channels. In red, channels expressed in the heart; underlined, channels clearly identified as MGC; *, channels with no known mammalian homologues. Only a selection of the more well-known channels and receptors is presented; protein names for mammals are explained in 61, 62 and in human heart. 63 In normal metabolic conditions, K ATP channels are inactivated. If ATP levels fall, K ATP open probability increases. In the presence of stretch, this increase occurs at less reduced ATP levels. 64 This may explain the difference between in vitro studies (where ATP levels have to be severely reduced to open K ATP ) and the in vivo setting (where stretch of cardiac tissue is present at all times and presumably elevated in regions with reduced ATP). It is thought that K ATP channels are gated by local bilayer tension, and that this is affected by the cytoskeleton. 65 K ATP channels may have a protective role in ischaemia. 66 Interestingly, stretch preconditioning, known to reduce ischaemia-reperfusion injury, is abolished by blocking K ATP channels. 67 Of note, cardiac K ATP channels are also present and active in fibroblasts, suggesting that one must consider cardiac pre/postconditioning effects on cells other than just cardiomyocytes. [68] [69] [70] As with other K + channels, K ATP opening favors re/hyperpolarization. Although beneficial in preventing spurious excitation of resting cells, this also shortens action potential (AP) duration and reduces the refractory period. The latter could help to establish an arrhythmogenic substrate and support re-entry.
Channel Activation: Cell Volume Versus Stretch
VAC are generally regarded to be MGC. That said, their mechanism of activation in the heart is poorly understood. What is known is that increases in cell volume, whether by swelling 71 or pipette-based cell inflation, 72 tend to activate chloride 71 or potassium conductances. 32 Although cell volume changes undoubtedly cause mechanical deformation, VAC-activation tends to occur with significant lag times (tens of seconds to minutes) after the onset of cell volume changes. 73 This has put into question the role of direct mechanical stimuli as drivers of VAC gating, and it has been suggested that swelling-induced changes in cytoskeletal structures must take place before mechanosensitive electrophysiological responses are seen. 74 In terms of pathophysiological settings, cell swelling can be observed in ischaemia, particularly upon reperfusion, 75 and VAC are understood to affect cardiac electrical behavior in these conditions. Interestingly, VAC-like Cl − conductances are constitutively activated in hypertrophied cardiomyocytes, 71 lending credence to the notion that structural aspects of cardiomyocyte organization matter. Recently, LRRC8A (a leucine-rich repeat containing protein 8A, aka SWELL1) has been identified by two independent groups as an essential component of the ubiquitous volume-regulated anion channels. 76, 77 This discovery has been a result of genome-wide RNAi screens and provided a new molecular candidate to better understand cell volume regulation.
At the same time, the normal cycle of cardiomyocyte contraction and relaxation is not generally assumed to be associated with pronounced changes in cell volume. This, and the lag time for VAC activation, makes it unlikely that these channels are main contributors to acute, beat-by-beat MEF (for more information on cardiac VAC see review by Baumgarten and Clemo 71 ). SAC-the quintessential MGC-increase their open probability in direct response to membrane deformation. Evidence demonstrating that lipid bilayer forces are sufficient to gate SAC was obtained for several bacterial, fungal, 78 and two vertebrate channels, TWIK-related K + channels (TREK-1) and TWIK-related arachidonic acid-activated K + channels (TRAAK). 79, 80 The small number of channels tested in this way is caused in part by technical difficulties to purify or produce functional channel reconstitutes in pure lipid bilayers. Also, several SAC are likely to require cytoskeletal and linker proteins, 81 and/or possibly soluble factors or messengers for activation. 82 Interestingly, mutations in cytoskeletal proteins have been linked to cardiac pathologies, [83] [84] [85] [86] including rhythm disturbances, 87, 88 though, thus far, this would not seem to act via effects on MGC but rather through effects on voltagedependent channels and transporters that indirectly affect cardiac excitation-contraction coupling. Several biophysical models have been proposed to address energetic interactions at the membrane-protein interface and contributions of lipid organization or, in addition to in-plane stress, changes such as membrane thinning have been suggested as relevant atomistic-level stimuli. [89] [90] [91] These models, mainly obtained from bacterial channels reconstituted in liposomes, suggest that MGC can be gated by forces from lipids in the range of hundreds of piconewton (eg, 220 pN for MscL). 92 More broadly, including eukaryotic channels in the cellular context (ie, in the presence of the cytoskeleton), it seems that MGC are sensitive to a wide range of force intensities characteristic for living cells, from 2 to 10 mN/m (data acquired on cultured cells). 93, 94 To understand the mechanical gating of SAC, structural data are needed. So far, the structure of MscL 95 and mechanosensitive channel of small conductance (MscS), 96, 97 as well as of mammalian TRAAK, 98 Piezo1, 99 and Big K + (BK) 100 channels, has been resolved at atomic resolution.
Nonsarcolemmal MGC: Sarcoplasmic Reticulum
Calcium handling in cardiac cells is mechanosensitive, involving mechanisms from changes in Ca 2+ buffering and troponin-C binding, to Ca 2+ fluxes. 105, 106 This includes Ca 2+ releasability from the sarcoplasmic reticulum (SR), such as evident in an increased frequency of SR Ca 2+ release events (sparks) upon acute mechanical stimulation, whether using axial cell stretch or local application of fluid puffs to deform isolated cells. 21, 104 Mechanisms underlying the stretch-induced increase in spark rate continue to be investigated and may include mechanical modulation of ryanodine receptor Ca 2+ -release channels of the SR. This could have functional relevance not only for priming SR Ca 2+ release and/or terminating it upon successful cell shortening, but it would also have the potential of affecting cardiac electrophysiology. If stretch promoted Ca 2+ release from the SR, this could affect trans-sarcolemmal Na 
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Nonsarcolemmal MGC: Other Organelles Mitochondrial K ATP channels contribute to ischemic pre- 107 and postconditioning, 108, 109 potentially protecting cells by maintaining ATP production during hypoxic episodes. 110 Although the molecular identity of the cardiac mitochondrial K ATP is still debated, it is possible that it shares mechanical modulation with its sarcolemmal counterpart (discussed in Ligand-Activated MMC section of this article).
The nuclear envelope shows significant deformation during application of mechanical forces to a cell. [111] [112] [113] Nuclear mechanosensing is an underappreciated research area with significant importance for the understanding of mechanically induced changes in cell behavior. 114 In terms of ion channels, TRPV4 (transient receptor potential channel, vallinoid, #4) was localized in cultured neonatal rat ventricular myocytes in the nucleus only, 115 although functional data confirming actual ion channel activity of this protein are still outstanding.
Of course, for MEF to affect heart rhythm, transmembrane potential changes must occur, and the focus on sarcolemmal MGC is, therefore, not merely a consequence of conceptual restrictions or technical constraints (in terms of channel accessibility by recording tools) but related to the focus on functional responses of interest and, thus, the topic of this review.
Beyond cardiomyocytes: another questionable preconception is that the normal heart consists chiefly of cardiomyocytes. Although true in terms of volume fraction, nonmyocytes, such as endothelial and interstitial cells, outnumber muscle cells in the heart. Endothelial cells of the cardiovascular system possess MGC, [116] [117] [118] and so do fibroblasts. [119] [120] [121] Although presumably required for functions, such as shear sensing and directional extracellular matrix protein deposition in response to mechanical clues, 122 ion channels in nonmyocytes may affect cardiac electrophysiology in the presence of heterotypic cell coupling in the heart. Such coupling seems to exist in native myocardium, both in normal [123] [124] [125] and fibrotic/scarred tissue, 126, 127 as reviewed in detail elsewhere.
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Cardiac SAC: Molecular Candidates Criteria and Terminology
Knowledge about molecular candidates for cardiac MGC has seen significant improvements over the past decade. Candidate proteins and protein families have emerged, and new, often complex regulatory contributions have been proposed. At the same time, specific information about mechanotransduction pathways remains relatively limited. To address present controversies, Arnadóttir and Chalfie 129 suggested 4 criteria to establish whether or not a protein forms an ion channel that transduces mechanical forces and is relevant for organ function: 1) the protein must be expressed and localized in the mechanosensory organ; 2) the channel is required for mechanosensitive responses but not merely for normal development of the mechanoreceptor cell or signaling downstream of the stimulus; 3) alteration of channel properties (conductance, kinetics, sensitivity, and selectivity) alter the properties of mechanical responses; and 4) the channel should be gated mechanically in heterologous expression system. In the mammalian heart, proteins have not generally been assessed as yet for these 4 criteria, highlighting avenues for further investigation.
In this review, SAC are subdivided by their ion selectivity into K + -selective (SAC K ) and cation nonselective channels (SAC NS ).
Stretch-Activated Channels, K + -Selective
Kim 32 described first whole-cell SAC k currents (I SAC,K ) in cardiac cells. SAC K are outwardly rectifying and allowing potassium ions to move more easily out of the cell than into it. They have large single-channel conductances and inactivate in a time-dependent manner. Their activation causes membrane re-or hyperpolarization. 64 Single-channel recordings of I SAC,K in adult mammalian cardiac myocytes have been obtained from atrial 32 and ventricular myocytes. 33, 130, 131 I SAC,K is thought to be carried by K 2P (K + , 2 P domain; a P domain is a short amino acid segment between 2 transmembrane helices that contributes to formation of the inner part of the pore, acting as a selectivity filter) channels expressed in the mammalian heart. 132 The most studied among them is TREK-1.
TREK and TREK-Like Channels
TREK-1 is active over a range of physiological membrane voltages. Channel gating is polymodal, activated by an impressive number of stimuli including intra-and extracellular pH, temperature, fatty acids, anesthetics, and crucially, membrane deformation (curvature) or stretch. 133 TREK-1 expression appears distinctly heterogeneous in the heart, with a gradient of mRNA expression that increases transmurally, from subepicardial to subendocardial myocytes. 134, 135 This heterogeneity seems to correlate with transmural changes in MEF sensitivity, whereas stretch causes the most pronounced AP shortening in the subendocardium. 136, 137 However, although TREK-1 mRNA expression was observed in murine atria and ventricles, 132, 134, 138, 139 it has not, to our knowledge, been found in the human heart. 140, 141 That said, whole-tissue mRNA, and even protein assays, are not necessarily true reflections of presence, let alone relevance, of a target, which may derive importance from high expression January 22, 2016 in a minority cell population (cardiac Purkinje fibers would be an example).
Where observed, TREK-1 protein appears to be arranged in longitudinal stripes on the surface of cardiomyocytes: a pattern that could support directional stretch sensing. 131 Wholecell currents exhibiting the characteristics of recombinant TREK-1 (including sensitivity to volatile anesthetics, arachidonic acid, pH, internal acidification, and stretch) have been observed in atrial and ventricular myocytes of several species including rat, mouse, and pig. 137, 142 In terms of functional relevance, TREK-1 contributes to the "leak" potassium conductance in cardiomyocytes. 137, 143 As such, it aids normal repolarization and diastolic stability. However, increased TREK-1 current, for example during stretch, could shorten AP duration to a degree where this becomes proarrhythmic. 136 In keeping with this, several wellestablished antiarrhythmic drugs, including lidocaine, mexiletine, propafenone, carvedilol, dronedarone, and vernakalant, inhibit TREK-1.
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TREK-2 shares functional similarity with TREK-1, although little is known about its functional relevance in the heart. It appears active in chicken embryonic atrial myocytes, 144 and it is expressed in rat atria. 132 TRAAK is a TREK-1 homologue with similar biophysical properties and regulation, 145 expressed in the human heart 132, 146 TRAAK might form a human TREK-1 homologue, but its specific functional relevance in the heart is not yet known.
The similarity of electrophysiological properties of TREK-1, TREK-2, and TRAAK, and the overwhelmingly high expression levels of TREK-1 in murine model systems, may explain the paucity of experimental data on TREK-2 and TRAAK function. It is possible to differentially study them, as volatile anesthetics activate TREK-1 and -2, but not TRAAK, 147 whereas extracellular acidification inhibits TREK-1 but activates TREK-2. 148 Detailed characterization of the functional relevance of these MGC in mammalian heart in general, and in human tissue in particular, is a prerequirement for consideration of their pathophysiological relevance and therapeutic target potential. This has, by and large, yet to occur.
BK Channels
BK channel activation is polymodal for a range of gating stimuli, which has given rise to different names for the same type of ion channel in a variety of studies (eg, SAK CA , BK Ca , SLO1, MaxiK). 149 They are present in a number of cell and tissue types, including vascular smooth muscle, atrium, and ventricles. 150 BK channels are found not only in the sarcolemma but also in membranes of the endoplasmic reticulum, the Golgi apparatus, and mitochondria. 149 Mechanosensitivity of BK channels was established in membrane patches excised from cultured embryonic chick ventricular myocytes. 151 However, as BK channels are activated by voltage changes and by alterations in intracellular Ca 2+ concentration, 150 it has been suggested that their mechanosensitivity is indirect, occurring secondary to stretch-induced changes in intracellular Ca 2+ concentration. 152 As implied by their name, BK channels have large conductances. They have been suggested to contribute to heart rate control 153 and to offer cardioprotection during ischaemia. 154 Genetic variants of BK have been related with increased severity of systolic and general hypertension, as well as increased risk of myocardial infarction. 155 
Stretch-Activated Channels, Cation Nonselective
Following on from the discovery by Guharay and Sachs 29 of stretch-activated ion currents in avian skeletal muscle, Craelius et al 30 identified SAC whole-cell currents in mammalian heart muscle. This current had the typical linear current-voltage relationship of weakly selective ion channels, which we now attribute to SAC NS (I SAC,NS ). In contrast to SAC K , SAC NS have smaller conductances and a reversal potential closer to 0 mV. With the reversal potential being positive to the resting potential of working cardiomyocytes, activation of SAC NS will depolarize resting heart muscle cells, potentially triggering premature or ectopic excitation. 64 In contrast to SAK K , no SAC NS single-channel recordings have been obtained from freshly isolated adult ventricular cardiomyocytes. This has led to the suggestion that SAC NS may be hidden from patch pipette access, in membrane regions such as T-tub, 156 caveolae, or at intercalated discs. 157 A recent report suggests that α1A adrenergic agonists may cause translocation of a putative SAC NS (transient receptor potential channel, canonical [TRPC]6) from T-tub to the sarcolemma. 158 Whether this occurs physiologically, and the extent to which it might serve as a useful experimental intervention to facilitate single-channel recordings of TRPC6 in adult ventricular myocytes, remains to be explored.
The main molecular candidates for SAC NS are Piezo and transient receptor potential (TRP) channels.
Piezo1 and 2
The discovery of Piezo1 and 2 by Coste et al 40 represents a breakthrough in the field of mechanotransduction. Piezo proteins form true SAC that meet the 4 criteria listed above. Stretch activation was demonstrated by heterologous expression of Piezo1 in human embryonic kidney cells, which induced robust I SAC,NS . Purified Piezo1, reconstituted into asymmetric bilayers and liposomes, forms ruthenium-red (a well-established pore blocker) sensitive ion channels, demonstrating that Piezo1 proteins are a pore-forming subunit of the channel. 159 Further investigation is required to clarify whether Piezo1 ion channel subunits are intrinsically mechanosensitive.
Currently, no functional data have been published on Piezo1 or Piezo 2 in the heart. However, as Piezo channel properties are similar to those of endogenous cardiac SAC NS , including (weak) voltage dependency, single-channel conductance, inactivation, and sensitivity to Grammostola spatulata mechanotoxin #4 (GsMTx-4), 160 it is tempting to think that Piezo contributes to cardiac MEF. 161 In terms of mRNA expression, Piezo1 has been observed in murine heart, 40 albeit at low levels in comparison with expression in lung, bladder, or skin. However, mRNA or protein expression in tissue should be interpreted with caution. The two do not necessarily correlate to one another, 162 and even if protein expression is confirmed, it does not necessarily prove the presence of functional ion channels. Vice versa, low expression levels do not rule out functional relevance of a protein, in particular, if it is present in a minority cell population (such as Purkinje fibers, whose mechanosensitivity was subject of the paper that coined the term cardiac MEF). 10 This is an exciting and area of dynamic development. Basic science questions concerning structure, protein partners, and regulation of Piezo channels need to be addressed, as does the question of whether they are present in, and relevant for, the human heart.
TRP Channels
Most mammalian TRP channels act as nonselective cation channels, passing Na + , K + , and in some cases Ca
2+
. They are widely expressed, involved in a variety of cell functions, and characterized by polymodal regulation. 163 Although the presence and extent of direct stretch activation of these channels have remained controversial, results from heterologous expression systems suggest that some TRP are good SAC NS candidates.
TRPC6 stretch activation was characterized in human embryonic kidney cells 164 but was not confirmed in CHO and COS cells (CHO is a Chinese hamster ovary cell line; COS is a transformed monkey kidney fibroblast cell line). 82 It has been suggested that TRPC6 requires the angiotensin II type 1 receptor to be mechanosensitive. 163, 165 TRPC6 is among a small number of SAC candidates that are highly expressed in human heart homogenates. 166 In mouse heart, TRPC6 appears localized in T-tub and, in agreement with this observation, detubulation inhibits I SAC,NS in murine ventricular cardiomyocytes. 49 Whole-cell patch clamp experiments on mouse cardiomyocytes identified robust I SAC,NS in response to shear stimuli, which was inhibited by pore-blocking TRPC6 antibodies. 49 Murine TRPC6 knockout models suggest that the channel contributes to the slow force response and may be involved in Duchenne muscular dystrophy, 167 highlighting the potential clinical relevance of TRPC6 manipulation. In nonmyocytes, TRPC6 is proposed to promote myofibroblast transdifferentiation, and it could act as a positive regulator in wound healing. 168 Putative roles, both in myocytes and nonmyocytes, make this channel an interesting target for therapeutic intervention.
TRPC1 mechanosensitivity is discussed controversially. Stretch activation of TRPC1 was first shown in Xenopus oocytes 169 but has not been confirmed in other expression systems. 82 Like TRPC6, this channel is likely to require the presence of a partner protein. Caveolin 1 has been reported to be a trafficking regulator of TRPC1. 170, 171 As caveolae are highly dynamic membrane regions, whose sarcolemmal integration is dynamically modulated by acute and sustained stretch, 172, 173 this observation points to the possibility that TRPC1 is mechano-modulated but not mechano-gated.
TRPC3 protein has been identified in rat ventricular myocytes, where it is located in T-tub. 174 In mouse neonatal cardiomyocytes, this channel is involved in reactive oxygen species production in response to mechanical stimulation or to perfusion of 1-oleoyl-2-acetyl-sn-glycerol (OAG), a nonspecific activator of MGC. 174 Recently, TRPC3/4 and 6 channels have been shown to contribute to pathological structural and functional remodeling after myocardial infarction. 175 Blocking these channels is suggested to reduce pathological remodeling and to improve contractility, making TRPC channels new therapeutic targets in the context of postmyocardial infarction.
TRPV2 is expressed in mouse heart 157, 176 and has been reported to be activated by both cell volume changes and patch pipette suction. 177 Using the TRPV2 agonist probenecid in wild-type and TRPV2 constitutive knockout mice, it was proposed that this channel contributes to baseline function of the cardiac calcium-handling machinery. 176 Like TRPC6, TRPV2 combines this putative physiological role with potential contributions to dystrophic cardiomyopathies in pathological settings. TRPV2 is overexpressed in dystrophic cardiomyocytes and contributes to Ca 2+ influx. Interestingly, in cardiomyocytes challenged by osmotic shock, TRPV2 trafficking is impaired, leading to an accumulation of the protein on the sarcolemma and along T-tub, instead of their normal preferred location in the membranes of internal Ca 2+ stores. 178 TRP melastatin (TRPM) 4 is expressed in cardiomyocytes of several species including mouse, rat, and human. 165 It has been implicated in stretch-activated responses of vascular smooth muscle. 179 Overexpression of TRPM4 may be involved in an inheritable form of progressive familial heart block type I, 67 though perhaps via mechanisms not directly related to TRPM4 mechanosensitivity. Its physiological role in the heart is currently unknown.
TRP polycystin (TRPP) 2 is primarily found on the endoplasmic/SR and in primary cilia. 180 However, a TRPP2-like protein seems to function as a channel in the plasma membrane of rat ventricular cardiomyocytes, 181 acting as a modulator of the cardiac ryanodine receptor. 182 Given its contribution to intracellular calcium cycling, TRPV2 dysregulation has been suggested to be involved in the development of heart failure.
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Pharmacological Modulators
The best-known pharmacological tools to alter SAC activity are blockers of limited specificity, including gadolinium ions, amiloride, and cationic antibiotics (streptomycin, penicillin, and kanamycin). Caution is needed, in this context, when interpreting research on stretch effects in cultured cells, as standard media contain antibiotics that may alter (reduce) background availability of SAC.
Despite of their limited selectivity, the above SAC blockers have been highly productive for experimental cell research, as reviewed elsewhere. 93, 184 Their utility in whole animal or human studies is limited though. Thus, gadolinium is chelated almost completely in solutions that contain physiological pHbuffer systems, 185 while clinically used compounds (amiloride, antibiotics) exert their effect primarily and predominantly via their established pharmacological targets, rather than possible (side-)effects on SAC. Also, not always is in vitro behavior indicative of in situ response patterns. Thus, streptomycin's ability to block stretch responses in isolated cells 185 is not necessarily preserved over the same concentration ranges and response times in native tissue, 186 highlighting the possibility of false-negative findings on SAC contributions probed using the antibiotic in more integrative model systems.
A number of other clinically applied compounds affect molecular SAC candidates with a relatively narrow spectrum January 22, 2016 of action. TREK-1 activity, for example, is modulated by the neuroprotective agent riluzole (10−100 μM), the antidepressant fluoxetine (Prozac; IC50-10 μM), and millimolar concentrations of volatile halogenated and gaseous general anesthetics, 145 in the case of channel activation with the potential for unexpected false-positive effects in studies on anaesthetized mammals.
Among the few specific SAC inhibitors identified is the peptide GsMTx-4, 160 isolated by the team of Fred Sachs from a Chilean tarantula venom. 187 In contrast to SAC K , SAC NS are distinctly sensitive to this peptide, although the mechanism of this specificity is unknown. GsMTx-4 inhibits TRPC5, 73, 188 TRPC6, 164, 189 and Piezo1 channels, when applied to the external membrane. 190, 191 Both the d and l enantiomers of GsMTx-4 block SAC NS , showing that the mechanism of action is not stereospecific or chiral. 192 Instead, the action of GsMTx-4 is thought to involve insertion into the outer membrane leaflet (GsMTx-4 is an amphipath) in the proximity of the channel, relieving lipid stress sensed by the channel and favoring the closed state of SAC. 192 Counterintuitively, GsMTx-4 sensitizes bacterial MscS and MscL to increased tension, 193 although it has no effect on TREK-1. 190 The mode of action of GsMTx-4 on SAC requires further elucidation.
A SAC K specific blocker is Spadin. It inhibits TREK-1 mechano-gating, 194 without affecting TREK-2 and TRAAK. 194 Additional TREK-1 modulators, including activators, have recently been identified by Bagriantsev et al, 195 and the utility of these compounds for cardiac MEF research awaits exploration. Cardiac potassium-selective MMC that have been probed using specific inhibitors include K ATP channels. The mitochondrial K ATP is inhibited by the 5-hydroxydecanoate (5-HD), whereas HMR-1098 (Aventis Pharma) has been identified as an antagonist for the sarcolemmal K ATP . 110, 196 Glibenclamide is also a popular pharmacological tool, inhibiting sarcolemmal K ATP from either side of the membrane. 197 Concerning TRP channels, TRPC6 antibodies have been used as specific inhibitors of stretch responses in isolated cells. 49 More generally, TRPC6 is modulated by hyperforin,
198
TRPV1 by capsaicin, 199 TRPV2 by probenecid, 200 and TRPM4 by 9-phenanthrol. 201 If specific inhibitors are rare, even fewer specific activators have been identified. Recently, Yoda1 has been shown to be an agonist for both human and mouse Piezo1, affecting sensitivity and inactivation kinetics of the channel. This compound does not act via protein partners of the channel as it is still efficient in artificial bilayers. 202 If confirmed in native heart tissue, it would represent a powerful tool to investigate Piezo1 functions in integrated systems, especially if the channel was closed in physiological conditions.
The potential for MGC and MMC modulators as pharmacological tools in heart rhythm management has been expertly reviewed by White. 106 Considering the ubiquitous presence of these channels in all cell types of the human body, pharmacological interventions targeting a specific organ are challenging, requiring selective delivery and avoidance of side-effects on other body functions. A possibility here is genetic targeting, with the potential of not only aiming for a specific organ, but for a specific cell type in that organ (cardiomyocytes, endothelial, interstitial or immune cells, etc.) or a defined disease progression stage. Again, this is a domain of research requiring additional effort/focus.
Mechanistic Projection Between Levels of Investigation
The heart generates, experiences, and responds to a highly dynamic mechanical environment. Parameters relevant for cardiac mechanoreception change dynamically and on a range of different time scales, from years (eg, ontogenesis, disease development, or aging) to fluctuations that are circadian (eg, physical activity), spread over tens of seconds (eg, respiratory cycle induced alternations in venous return), or happen in milliseconds (eg, mechanical activation during a heartbeat). MGC are, jointly with phototransduction systems, among the most rapid sensors in biological systems, although they may make contributions over the whole range of time scales mentioned above. Knowledge about SAC contributions to chronic cardiac conditions is limited, although they have been implicated in the development of cardiac hypertrophy and heart failure. [203] [204] [205] Identification of causal chains of events is difficult in chronic disease, as a host of relevant parameters, from tissue and cell viscoelastic properties to ion channel expression, 206 remodel. Projection from SAC activity to cell and tissue levels during acute stretch-induced changes in cardiac electrophysiology is more straightforward. Activation of SAC K , with their reversal potential negative to the resting membrane potential of cardiac cells, will tend to hyperpolarize resting cells. SAC NS , in contrast, with reversal potentials typically between 0 and −20 mV in cardiac cells, will depolarize resting cells, if sufficient current flow is generated. 207 Interestingly, all stretchinduced changes in resting membrane potential of cardiac myocytes reported so far involve depolarization, up to and including mechanical induction of AP. 15 Resting membrane depolarization can be explained by SAC NS but not by SAC K , suggesting that the latter do not normally determine acute electrophysiological response patterns of the heart to diastolic mechanical stimulation.
Matters get more complicated during the AP, when timing of mechanical stimuli warrants closer examination. Although SAC K activation would continue to have a re-or hyperpolarizing effect, SAC NS will do so only while membrane potential levels are positive to the SAC NS reversal potential. As a consequence, SAC NS activation will shorten AP duration during early repolarization but may, if sustained or applied late in the AP, give rise to late AP prolongation, or even after-depolarization-like events (Figure 3) . Indeed, both early and late stretch-induced after-depolarization-like behavior have been reported in cardiac research. 64 If suprathreshold, these may mechanically trigger ectopic excitation. 208 Timing dependence of stretch effects on cellular electrophysiology matters also for the projection from cell to organ/ organism levels, as both electrical activation and repolarization are characterized by a wave-like behavior across the heart. This means that the ECG offers an inherently limited temporal reference for characterization of local events, as illustrated in more detail in Clinical Relevance section of this article.
Quantitative projection from molecule to organism, including elucidation of spatiotemporal modulators of stretch responses, has benefitted from computational modelling. [209] [210] [211] Interestingly, the vast majority of observed acute electrophysiological responses of the heart to stretch can be successfully reproduced simply by invoking SAC NS . 212 Of course, computational demonstration of quantitative plausibility is neither proof nor replacement of experimental validation. Occasionally, validation trails computational predictions by a decade or more. An example is models of impact-induced arrhythmogenesis (aka Commotio cordis [CC], agitation of the heart, without structural damage), 3, 4 whichusing 2D 213 and 3D 214 simulations-concluded that the rare but devastating CC-induced ventricular fibrillation (VF) requires spatiotemporal overlap of mechanically affected tissue with the trailing edge of the repolarization wave. This has now been confirmed experimentally (see also Clinical Relevance section of this article). 215 Among the present challenges in projecting from protein to pathology is the difficulty of assessing and comparing actual effective mechanical parameters of ion channel stimulation. Few studies have quantified the stretch imparted upon patch-clamped membranes during SAC investigations. 216 At the cell and tissue level, cell or sarcomere length are used as a readout of strain, 217 and occasionally as an input parameter to gauge mechanical modulation of cardiomyocytes. 24, 218 In native heart, implanted ultrasonic transducers, 219 echo, and magnetic resonance imaging 220 have all been applied to characterize transmural deformation patterns. But, and this is a crucial limitation, none of these techniques allows one to actually measure stress/force inside the preparation (whether a membrane patch, a cell, or a tissue/organ). An exciting development here is the advent of fluorescent force reporters, 221 whose application to cardiac MEF research could revolutionize concepts and understanding of cardiac mechanosensitivity.
Clinical Relevance
In terms of physiological beat-by-beat effects, activation of SAC has been shown to underlie the non-neural component of the stretch-induced increase in spontaneous sinoatrial node cell pacemaking rate, aka the Bainbridge effect. 20 Block of SAC using GsMTx-4 (but not using streptomycin, see Pharmacological Modulators section of this article) terminates this positive chronotropic response in native sinoatrial node tissue explants 186 which, in its guise of a respiratory sinus arrhythmia, persists at whole body level-even in heart transplant recipients and/or after additional pharmacological denervation. 222 Surprisingly, this is about all we know for sure regarding the physiological relevance of SAC in heart rate and rhythm regulation.
It is possible, perhaps probable, that the key role of cardiac SAC under normal conditions is related to autoregulation of contractile behavior. This could occur via stretch-dependent adjustment of trans-sarcolemmal Ca 2+ influx, 223 preservation of intracellular Ca 2+ secondary to stretch-induced trans-sarcolemmal influx of Na + , 152, 224 and/or stretch-modulated grading of Ca 2+ release from the SR. 21 Any or all of these mechanisms could contribute to both acute (Frank-Starling response) 225 and sustained (slow force response) 226 adjustments of cardiac contractility to changes in the heart's mechanical environment (highly relevant for contractile cells in the heart, given that they are not controlled via neuromuscular junctions, such as is the case in skeletal muscle), whereas their effects on cardiac electrophysiology would be secondary.
In contrast, SAC have been implicated in a host of clinically relevant scenarios, from acute arrhythmogenesis to sustenance and termination of arrhythmias, as explored next.
Mechanical Induction of Arrhythmias (Acute)
As mentioned before, stretch of resting myocardium, if strong enough to cause any change in membrane potential, gives rise to depolarization, potentially triggering ectopic excitation. In human volunteers, this has been shown to occur upon external mechanical energy delivery, such as by precordial tapping, at energy levels as low as 0.04 J (equivalent to dropping a golf ball [46 g ] from a height of 9 cm). 227, 228 Mechanically induced ectopy is a common adjunct to intracardiac device-tissue interactions such as during cardiac catheterization, 229 and it may even be triggered by the heart's own mechanical activity, such as upon acute obstruction of ventricular outflow during balloon valvuloplasty. 230 Mechanically induced ectopy is usually benign, but in the context of pre-existing pathologies, it may give rise to sustained tachyarrhythmias. In a porcine model of pathologically prolonged QT-intervals, for example, β-adrenergic stimulation by bolus injection of isoproterenol can give rise to ventricular after-contractions, originating from near-endocardial locations. These after-contractions precede early afterdepolarization-like behavior in near-epicardial tissue. Upon reaching threshold for induction of ectopic excitation, this can initiate torsades de pointes. 231 Much rarer than mechanically induced ectopy, but more widely known, is CC, in particular, in its most severe form of CC-induced VF. Here, a mechanical impact on the precordium, usually by a projectile such as an ice hockey puck or baseball, gives rise to acute MEF responses that, during a very narrow critical window of about 15-20 ms, can cause instantaneous induction of VF. 232 The mechanisms underlying VF induction are discussed controversially, with focus either on abnormal repolarization 233 or on abnormal excitation overlapping the trailing edge of normal repolarization. 3 Also, the role of the impact-associated surge in intraventricular pressure is subject of debate, although it is accepted that local mechanically induced ectopy occurs in myocardium nearest to the site of mechanical stimulation, both in isolated heart 215, 234 and whole animal. 234 Recent optical mapping studies of isolated heart models of CC have confirmed that SAC NS are involved in the generation of ectopic excitation, and that deterioration into VF is seen only if ectopy occurs right on the edge of the preceding normal repolarization wave. 215 This confirms prior modelingbased predictions 213 and sheds further light on the unusually narrow critical window for mechanical induction of VF in whole animal studies: the precondition for overlap of mechanical stimulus and trailing repolarization edge is met for any specific precordial impact location for a brief part of the ECG cycle only (if one could mechanically stimulate other parts of the heart by extracorporeal impact, the accompanying critical time window would be shifted). Thus, the critical window for VF induction during CC exists in time and in space, highlighting that systemic (ECG) and local (AP) timings are not interchangeable.
Mechanical Sustenance of Arrhythmias (Chronic)
Mechanical contributions to chronic arrhythmias have been implicated in the perpetuation of both atrial [235] [236] [237] and ventricular tachycardias. 238 Mechanisms here may range from activation of SAC that alter AP duration, 239 slow conduction velocity, 173, 235, 238 or increase dispersion of repolarization, 238 over changes in expression of mechanically modulated ion channels 206 and alterations in connexin phosphorylation 240 to remodeling of tissue architecture, composition, 241 and innervation. 242 Given the multiplicity of mechanisms and pathways involved and the variable time scales over which they manifest themselves, this area is understudied, in particular, with regard to ventricular arrhythmogenesis. A conceptually interesting approach to probing effects of sustained ventricular stretch in cardiac arrhythmogenesis has been employed by Waxman et al, 243 who used the Valsalva manoeuvre to temporarily reduce ventricular volume overload in tachycardic patients, achieving spontaneous return to normal sinus rhythm. Because the intervention also works in heart transplant recipients, 12 the most probable explanation is that sustained stretch is proarrhythmogenic.
The demonstration of tachycardia termination by temporary reduction in ventricular load highlights that chronic mechanical effects on heart electrophysiology are a clinically relevant target for further research. A perhaps particularly important aspect is the border zone of local (post-)ischaemic foci, 244 where mechanically promoted arrhythmogenesis 245 has been prevented in whole animal studies by application of a mechanical constraint that curtails ischaemic segment lengthening during contraction of the surrounding healthy myocardium. 246 The same intervention delayed extracellular potassium accumulation, suggesting mechanical modulation of transmembrane ion fluxes, perhaps involving sarcolemmal K ATP channels.
Mechanical Termination of Arrhythmias
Beyond removal of sustained overload, acute mechanical interventions, such as by precordial thump ("fist-aid"), have been known for at least a century to be of therapeutic potential. 247 It is assumed that the short sharp impact on the chest is transmitted to the heart, where-presumably via activation of SAC NS -it triggers ectopic activation in excitable tissue. 248 Such activation can be used to pace the quiescent heart or to obliterate excitable gaps in hearts containing re-entrant activation waves.
The latter scenario is less straightforward, given that excitable gaps, in particular, in the presence of multiple re-entry pathways, are unlikely to be accessible from the limited extent of precordial impact locations. In addition, in conditions of severe pre-existing ischaemia, the depolarizing effect of SAC NS activation may be off-set, in part, by ischaemic and mechanical coactivation of K ATP channels, 58 potentially rendering mechanically induced depolarization less effective. 229 Accordingly, early hopes, based predominantly on (publication-bias prone) case reports 249 for thump version of tachyarrhythmias, have not been sustained in more recent prospective human study designs. [250] [251] [252] [253] Accordingly, precordial thump application has been discouraged in recent advice by the International Liaison Committee on Resuscitation (ILCOR). 254 Precordical thump-pacing in bradycardia or primary asystole, however, remains a potentially productive intervention, 255, 256 for example, to bridge between witnessed asystolic arrest and application of electrical device-based rhythm management. 257 As evident form the 2010 ILCOR statement, precordial thump in asystole warrants further investigation, taking us full circle to the original 1920 paper by Schott, 247 who kept patients with Stokes-Adams syndrome during episodes of intermittent atrioventricular conduction block conscious for extended periods of time by mechanical fist-pacing only.
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Outlook
By and large, acute electrophysiological responses of the heart to mechanical stimulation can be explained, qualitatively and quantitatively, through activation of SAC. This in itself does not prove that they are sole or main drivers of responses. But, given the ability of increasingly selective pharmacological tools to probe responses in model systems from patch to patient, it seems reasonable to consider these ion channels as clinically relevant targets for management or correction of cardiac electrical activity.
So-What Are the Challenges?
At the basic science end, the perhaps most important question relates to the mechanism(s) of activation of MGC. Mechanical stimuli span all scales form nano to macro (an overview of the sizes of main mechanosensitive structures and proteins can be found in Figure 4 ). Their quantification in living systems is particularly challenging at cellular and subcellular levels.
It is known from in vitro experiments that sarcolemmal in-plane tension, curvature and thickness, as well as lipid composition, affect MGC activity. In addition, the cytoskeleton can gate MGC. Nonsarcolemmal responses, such as the stretch-induced increase in calcium spark rate, require the integrity, here of microtubules. 21 Sarcolemmal TREK channels are inhibited by actin, 143 whereas Piezo1 channels need the actin cytoskeleton to fully activate. 258 In addition, Piezo1 can be inhibited by the cytoskeleton-protein cross-linker filamin A in smooth muscle. 259 Thus, the cytoskeleton may, cause MGC activation or protect them from opening. An additional layer of complexity arises from the fact that cytoskeletal integrity affects membrane tension and shape of the cell and its organelles. 260 This may provide a further, potentially indirect, path to affecting MGC gating. Thus, even though MGC were discovered 3 decades ago, the actual biophysics of channel activation in vivo has remained elusive. 261 That said, membrane stretch is usually taken to be the obvious driver of MGC activation, but what are the relevant properties and descriptors of such stretch? Existence and extent of in-plane tension in membranes of cardiac cells is not known. What is known is that lipid bilayers are not distensible (strain exceeding 2-3% of slack area causes membrane failure), [262] [263] [264] so reservoirs (membrane invaginations, vesicles, caveolae) 172, 173, 265 are known to buffer membrane tension variations via quick (<100 ms) 266 membrane surface adaptation. 267 Thus, in-plane membrane tension may not increase linearly with stretch, rising more prominently when some of the membrane reserves have been extinguished. 268 This condition may be present in vitro more frequently than in vivo, as cells swell upon isolation, "losing" structurally identifiable caveolae, and hence, potentially biasing experimental observations. This could include either heighted mechanoresponsiveness or reduce differential stretch effects, as a result of preactivation of certain mechanosensitive pathways.
Related to tension (via the law of Laplace), but presumed to be an independent activator of MGC, membrane curvature is present both in the plasma-and in endomembranes. Effective strains are related to size and shape of mechanosensitive structures, and it is thought that curvatures only with radii in the range of ion channel dimensions (ie, few nanometers) 269 will act as directly relevant signals. Although optical monitoring of membrane curvature in live samples (membrane patches and cells) is possible, this tracks larger radii only. A real understanding, therefore, of the biophysics involved in translating a macroscopic mechanical stimulus into a microscopic event, capable of increasing the open probability of an ion channel, is one of the key missing ingredients in developing a mechanistic understanding of mechano-electric coupling.
Thankfully, techniques are emerging that will allow quantification of mechanical properties experienced by individual cells in the tissue.
Förster resonance energy transfer-based tension probes have started to be used to assess dynamic changes in cytoskeletal tension, thus far in noncardiac cells. This measuring approach is based on the energy transfer between 2 chromophores whose distance changes as a function of the mechanical environment. As the efficacy of energy transfer (which is measured as a shift in emitted fluorescence) is inversely proportional to this distance with a power of 10 6 , Förster resonance energy transfer probes are highly sensitive to minute changes in strain, and they can be used in vivo to characterize cytoskeletal tension in real time. 221, 277, 278 A conceptually similar approach is being taken toward assessment membrane mechanical properties in native cells. Using a Förster resonance energy transfer tension probe, inserted into a mechanosensitive protein, it has been possible to track conformational changes at the ion channel level in living cells. 279 Constructs like this could be used as tension reporters for various lipid bilayers, including nonsarcolemmal membranes.
At the applied end, one of the key challenges is to identify the molecular nature of individual ion channels involved in electrophysiological responses of the human heart to changes in the mechanical environment. Building on that, intervention tools that are organ-, or better cell-and/or disease-state specific, may hold a key to novel therapeutic opportunities.
A more long-term aim will be to decipher the complex pathways of mechanically induced changes in cell and tissue structure and function, which contribute to chronic responses to mechanical overload. Given that we are still unsure whether stress or strain is the key activators of MGC, it is difficult to decipher response patterns driven by volume-and pressurechallenges (or by pre-and afterload) in the whole organ.
The most complex setting-chronic overload combined with acute stretch (such as may occur in ischaemic border zone tissue)-is perhaps the clinically most relevant immediate target, as focal excitation occurs acutely and in relation to local stretch maxima. An MGC modulator that would be metabolic state specific (eg, perhaps pH-dependent) could potentially be applied systemically, yet act where needed. This is an area deserving targeted study.
Another challenge lies in the multiplicity of nonchannel structures that are mechanosensitive, 280 making an understanding of the roles of mechanical forces more complex.
Caveolae are known to act as membrane reserves that can buffer variation of membrane tension. They were shown to limit VAC (I Cl,swell ) activation in rat ventricular myocytes 267 and were implied as the substrate for stretch-induced conduction slowing (acting via mechanical unfolding, increasing effective surface membrane area). 173 Also, caveolin 3 can modify integrin function and mechanotransduction in cardiomyocytes and intact heart, 281 whereas caveolin 1 in endothelial cells of murine coronary arteries is a critical requirement for shear stress-mediated vasodilatation. 282 Caveolins are also tightly linked to some TRP channels, making caveolae another most interesting component of mechanical transduction pathways, including those relevant for MEF.
Last, but not least, T-tub-sarcolemmal membrane invaginations that dive deep into the centre of cardiac myocytescontains MGC (eg, TRPC6) and MMC (eg, Kir2.3). 49 They deform rhythmically on a beat-by-beat basis 172, 283 and may be one of the more underestimated physiologically relevant mechanotransducers in the heart. For a more extensive overview of nonchannel structures involved in mechanotransduction processes, we refer to Hirata et al. 280 
Conclusion
MGC in the heart affect cardiac electrophysiology. Although mechanical activation of ion transport pathways may be an evolutionary inheritance of the need, even for the earliest cells to respond to osmotic challenges, SAC in (osmotically more stable) multicellular systems may have conferred other advantages. For muscle cells, this may include the adjustment of contractility to local mechanical demand. The fact that MGC carry ion currents that can affect heart rate and rhythm may, thus, be a side effect. But, even if so, it is one that matters for maintenance of normal heart rate and for the induction or termination of heart rhythm disturbances. Any therapeutic targeting will need to involve a 3-pronged approach that considers potential electrophysiological benefits in the context of the need to maintain volume regulatory capacity (say in ischaemia, and even more so, reperfusion) and the ability to tune cell contractility to the mechanical environment. 284 In fact, the latter is particularly important for the heart as, in contrast to skeletal muscle, individual myocytes must match their mechanical performance to that of their neighbors in the absence of neuromuscular junctions or other cell external mechanisms to grade contractile activity. What is clear, therefore, is that any concept of cardiac electro-mechanical activity that ignores the information flow from mechanics to electrics is unnecessarily limited-and outdated.
